ImmuneCyte Life Sciences Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Corporate

  • Financing Rounds
  • 2

  • Investments
  • 2

ImmuneCyte Life Sciences General Information

Description

Provider of immune cell banking services committed to offering cell-based immunotherapy treatment solutions to clients. The company through its thermogenesis' proprietary car-txpress platform, aims to provide immune cells storage services at a tangibly lower cost.

Contact Information

Website
www.immunecyte.com
Ownership Status
Privately Held (backing)
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 185 Technology Drive
  • Suite 150
  • Irvine, CA 92618
  • United States
+1 (833)
Primary Industry
Other Pharmaceuticals and Biotechnology
Other Industries
Other Healthcare Services
Vertical(s)
Life Sciences
Corporate Office
  • 185 Technology Drive
  • Suite 150
  • Irvine, CA 92618
  • United States
+1 (833)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ImmuneCyte Life Sciences Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore ImmuneCyte Life Sciences‘s full profile, request access.

Request a free trial

ImmuneCyte Life Sciences Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore ImmuneCyte Life Sciences‘s full profile, request access.

Request a free trial

ImmuneCyte Life Sciences Investments & Acquisitions (2)

ImmuneCyte Life Sciences’s most recent deal was a Merger/Acquisition with Boyalife (Cellular Therapy Division). The deal was made on 08-Mar-2021.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Boyalife (Cellular Therapy Division) 08-Mar-2021 Merger/Acquisition Biotechnology
ImmuneCyte (Worldride IP) 13-Apr-2020 Corporate Asset Purchase Buildings and Property
To view ImmuneCyte Life Sciences’s complete investments and acquisitions history, request access »

ImmuneCyte Life Sciences FAQs

  • When was ImmuneCyte Life Sciences founded?

    ImmuneCyte Life Sciences was founded in 2019.

  • Where is ImmuneCyte Life Sciences headquartered?

    ImmuneCyte Life Sciences is headquartered in Irvine, CA.

  • What industry is ImmuneCyte Life Sciences in?

    ImmuneCyte Life Sciences’s primary industry is Other Pharmaceuticals and Biotechnology.

  • Is ImmuneCyte Life Sciences a private or public company?

    ImmuneCyte Life Sciences is a Private company.

  • What is the current valuation of ImmuneCyte Life Sciences?

    The current valuation of ImmuneCyte Life Sciences is .

  • What is ImmuneCyte Life Sciences’s current revenue?

    The current revenue for ImmuneCyte Life Sciences is .

  • How much funding has ImmuneCyte Life Sciences raised over time?

    ImmuneCyte Life Sciences has raised $3M.

  • Who are ImmuneCyte Life Sciences’s investors?

    HealthBanks Biotech USA and ThermoGenesis Holdings have invested in ImmuneCyte Life Sciences.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »